Primary hepatocellular carcinomas |
6/25 |
24 |
[40] |
Hepatocellular carcinoma cell lines |
3/7 |
43 |
[40] |
Non-small cell carcinoma cell lines |
10/19 |
53 |
[81] |
Non-small cell carcinomas |
11/18 |
61 |
[82] |
Matching normal tissue |
2/8 |
25 |
[82] |
Non-small cell carcinoma cell lines |
2/11 |
18 |
[82] |
Gastric carcinomas |
29/97 |
30 |
[33] |
Gastric cancer cell lines |
5/7 |
71 |
[33] |
Prostate carcinomas |
13/27 |
48 |
[85] |
Matching normal tissue |
2/27 |
7 |
[85] |
Benign prostate hyperplasia |
15/21 |
71 |
[85] |
Normal prostate tissue |
0/10 |
0 |
[85] |
Breast carcinomas |
5/14 |
36 |
[34] |
Breast carcinoma cell lines |
3/9 |
33 |
[34] |
Breast carcinomas |
4/39 |
10 |
[94] |
Breast carcinoma cell lines |
5/20 |
25 |
[94] |
Nasopharyngeal carcinomas |
31/39 |
79 |
[86] |
Nasopharyngeal carcinomas |
64/72 |
89 |
[34] |
Nasopharyngeal carcinoma cell lines |
11/12 |
91 |
[34] |
Oesophageal carcinomas |
48/94 |
51 |
[34] |
Oesophageal carcinoma cell lines |
6/15 |
40 |
[34] |
Cervical carcinomas |
7/8 |
87 |
[34] |
Cervical carcinoma cell lines |
5/8 |
63 |
[34] |
Renal cell carcinomas |
12/34 |
35 |
[95] |
Matching normal tissue |
1/34 |
3 |
[95] |
Renal carcinoma cell lines |
1/7 |
14 |
[95] |